Dispatch Biotherapeutics
PrivateLast Round
Series A
Jul 23, 2025
Total Funding Raised
$216M
Company Overview
Dispatch Biotherapeutics is a biotechnology company that develops immunotherapy-based cancer treatment technologies designed to expand curative potential across solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dispatch Biotherapeutics Comparables
Compare Dispatch Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CREATE Medicines | 81% | |
| Eureka Therapeutics | 77% | |
| ArsenalBio | 76% | |
Dispatch Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 23, 2025 |
Key People
Founding team and executive leadership
Dispatch Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Pennsylvania Office of Investments | Series A |
| Stanford University | Series A |
| ARCH Venture Partners | Seed, Series A |
| Parker Institute for Cancer Immunotherapy | Seed, Series A |
| ARCH Venture Partners | Series A |
| Alexandria Venture Investments | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Collaboration with University of Pennsylvania and other leading institutions.
- Jan 16, 2026
Partnering with CARsgen Therapeutics to develop CAR-T cell therapies.
Dispatch Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dispatch Biotherapeutics's valuation, stock price, and market status.